Schechter Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$26.1M Sell
291,300
-852
-0.3% -$79.5K 2.15% 10
2024
Q4
$29.1M Sell
292,152
-2,159
-0.7% -$223K 2.23% 8
2024
Q3
$33.4M Sell
294,311
-983
-0.3% -$117K 2.46% 4
2024
Q2
$36.6M Buy
295,294
+253
+0.1% +$32.6K 2.75% 4
2024
Q1
$38.9M Sell
295,041
-61
-0% -$7.52K 2.91% 4
2023
Q4
$32.2M Sell
295,102
-1,095
-0.4% -$114K 2.79% 2
2023
Q3
$30.5M Sell
296,197
-674
-0.2% -$72.6K 2.95% 4
2023
Q2
$34.3M Buy
296,871
+63,036
+27% +$7.16M 3.08% 2
2023
Q1
$24.9M Sell
233,835
-2,896
-1% -$313K 2.3% 4
2022
Q4
$26.3M Sell
236,731
-733
-0.3% -$74.9K 2.4% 3
2022
Q3
$20.5M Buy
237,464
+64,519
+37% +$5.76M 2.02% 4
2022
Q2
$15.8M Buy
172,945
+1,279
+0.7% +$113K 1.53% 6
2022
Q1
$14.1M Buy
171,666
+5,338
+3% +$421K 1.31% 7
2021
Q4
$12.7M Buy
+166,328
New +$13.2M 1.15% 9

Other funds holding MRK

Schechter Investment Advisors's MRK Position: Q1 2025 in Review

Schechter Investment Advisors reduced its Merck (MRK) stake by 0.29% in Q1 2025, selling an estimated $79.5K and leaving 291,300 shares worth $26.1M. The position accounts for 2.15% of the portfolio, ranked #10.

Schechter Investment Advisors first reported a position in MRK in Q4 2021 and has held it in 14 quarters since. The position peaked at $38.9M in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Schechter Investment Advisors held 291,300 shares of Merck worth $26.1M as of Q1 2025.
  • Schechter Investment Advisors sold 852 Merck shares in Q1 2025, an estimated $79.5K.
  • Merck made up 2.15% of Schechter Investment Advisors's portfolio in Q1 2025, its #10 holding.
  • Schechter Investment Advisors first reported a position in Merck in Q4 2021 and has held it in 14 quarters since.
  • Schechter Investment Advisors's Merck position peaked at $38.9M in Q1 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.